Prof. Dr. Ayşen Bingöl
-
★2021Co-authorship in Nature Immunology — C5 inhibition in CHAPLE diseaseNature Publishing GroupPioneering work on therapy for a rare primary immunodeficiency
What Prof. Dr. Ayşen Bingöl does
Treatment of asthma, primary immunodeficiencies, and food allergy in children.
-
01Biologic therapy for severe asthmaMepolizumab and others — 2026 publications
-
02Allergen-specific immunotherapy (AIT)Allergic rhinitis and food allergy
-
03Diagnosis of primary immunodeficienciesIncluding CHAPLE / CD55 deficiency
-
04Tolerance induction in food allergyOral immunotherapy programmes
Timeline
Career milestones.
Scientific work
163 publications, 1,500+ citations; landmark Nature Immunology paper (2021).
-
2024Frontiers in Allergy«Milk ladder: Who? When? How? Where? with the lowest risk of reaction»· co-author
-
2025Journal of Paediatrics and Child Health«Potentially Overlooked Risk for Neuropsychiatric Symptoms in Children: Montelukast Treatment»· co-author
-
2025European Journal of Human Genetics«BCL11B-related disease: a single phenotypic entity?»· co-author
-
2024Journal of Pediatric Pharmacology and Therapeutics«Successful Desensitization With ELX/TEZ/IVA»· senior author
-
2025International Journal of Cancer«High malignancy rate in IgE-deficient children»· senior author
Where they practise
Direct contract with BergemHealth at every listed clinic.
Tell me about your case — I’ll read it personally.
Fill in the short form on the consultation page — diagnosis, preferred timing, attached records. We assemble a tumour board for your case and reply within 4 hours.
Open the consultation form- Reply within 4 hours during business hours
- Confidentiality guaranteed
- Coordinator-translator inside the doctor’s office
- Tumour board of 2–3 professors within 72 hours
Similar BergemHealth professors
Adjacent specialties and second opinions. Direct contracts, verified cases.